If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

 

Susan gained her BPharm from the University of Nottingham in 1991, qualified as a Pharmacist (RPSGB) in 1992 before receiving her PhD in Medicinal Chemistry, from the University of Bath in 1995 for a thesis entitled "Synthesis of Biodegradable Polymers for Delivery of Diagnostic Agents". She gained Post-Doctoral experience at the Institute of Macromolecular Chemistry, Prague (Royal Society European Fellowship), Johannes Gutenberg Universität, Mainz and the Inorganic Chemistry Laboratory, Oxford before taking up the Kinerton Lectureship of Organic Chemistry at Trinity College, Dublin.  She joined the School in April 2003 as Lecturer of Medicinal Chemistry and was promoted to Senior lecturer in 2008.

She is currently the Chair of the University South East Asia Dialogue Group and was the Associate Dean for Admissions for the Faculty of Science from 2011 till 2016

 

PhD Positions

Click here for current PhD opportunities in PHA. But feel free to email me to discuss projects outside these areas and alternative sources of funding.

 

Selected Publications

 

K. Buffet, I. Nierengarten, N. Galanos,E. Gillon, M. Holler,A. Imberty, S. E. Matthews, S. Vidal, S. P. Vincent,J.-F. Nierengarten

Pillar[5]arene-based glycoclusters: synthesis and multivalent binding to pathogenic bacterial lectins

Chem. Eur. J., 2016, 22, 2955-2963

 

A. M. Boukerb, A. Rousset, N. Galanos, J.-B. Méar, M. Thepaut, T. Grandjean, E. Gillon, S. Cecioni, C. Abderrahmen, K. Faure, D. Redelberger, E. Kipnis, R. Dessein, S. Havet, B. Drablade, S. E. Matthews, S. de Bentzmann, B. Guéry, B. Cournoyer, A. Imberty, S. Vidal

Anti-adhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection

J. Med. Chem., 2014, 57, 10275-10289

 

Y. Brissonnet, C. Ortiz-Mellet, S. Morandat, D. Deniaud, S. E. Matthews,  S. Vidal, K. El Kirat S. G. Gouin

Topological effects and binding modes operating with multivalent iminosugar-based glycoclusters and glycosidases

J. Am. Chem. Soc. 2013, 135, 18427-18435

 

S. Cecioni, J.-P. Praly, S. E. Matthews M. Wimmerová, A. Imberty, S. Vidal

Rational design and synthesis of optimized glycoclusters for multivalent lectin-carbohydrate interactions: Influence of the linker arm.

Chem. Eur. J. 2012, 18, 6250-6263   

Administrative Posts

 

Chair of South East Asia Dialogue Group

Chair of Pharmacy Extenuating Circumstances Panel

School of Pharmacy Plaigiarism and Collusion officer

Member of School Teaching Executive

Member of School Examinations Board

Module coordinator: Drug Design and Mechanisms of Drug Action

Teaching Interests

I teach Medicinal Chemistry and Molecular pharmaceutics from Year 2 onwards.

Current teaching responsibilities include:

  • PHA5001Y Drug Design and Mechanism of Drug Action
  • PHA6004Y Evidence based care of Cardiovascular and Renal Disease
  • PHA6012Y Therapeutic Approaches to Gastrointestinal Diseases and Cancer
  • PHA7001B Neurology and Mental Health
  • PHA7003B Special Topics for Pharmacists
  • PHA7004Y Pharmaceutical Research Project

Key Research Interests and Expertise

Research is focused on the interface between chemistry and biology and particularly on the use of supramolecular systems for drug and gene delivery and in novel antibacterial treatments. Current projects include:

  • Gene delivery through functionalised multicalixarenes
  • Cell imaging using fluorescently labelled macrocycles
  • Anti-adhesives as an approach to antibacterial treatment
  • Site-specific pro-drug systems for new anti-cancer agents
  • New antibiotics related to algae extracts
  • New cation and anion receptors based on calixarenes
  • Synthesis of new macrocyclic systems

 

External Activities

Learned Societies

  • Fellow of the Royal Society of Chemistry and Chartered Chemist.
  • Member of the Royal Pharmaceutical Society of Great Britain
  • General Pharmaceutical Council Registered Pharmacist
  • Member of the American Chemical Society

Patents

  • Glycomimetic compounds as anti-infectious agents against pathogenic lectins, A Imberty, S Vidal, B Guery, S.E. Matthews, K Faure, S Cecioni, December 2010

  • Bromophenol compound, method for producing thereof and composition comprising the same, Hyi-Seung Lee, Seungil Park, Susan E. Matthews, Elise Bouthenet, September 2011

Invited Reviews/Book chapters

  • Calix[4]sugars: finally realising their therapeutic potential? Matthews SE in Calixarenes and Beyond, Eds P. Neri, J. L. Sessler, M-X Wang, Springer, 2016
  • Encapsulation of drug molecules into calix[n]arene nanobaskets. Role ofaminocalix[n]arenes in biopharmaceutical field, Ukhatskaya, E, Kurkov, S. Matthews, SE and Loftsson T, J. Pharm. Sci., 2013, 102, 3485-512
  • O-alkyl resorcarenes: Where are we now?, Moore D and Matthews SE J. Incl. Phenom. Macrocylc. Chem, 2009, 65, 137-155
  • Calix[4]tubes and calix[4]semitubes, Matthews SE and Beer PD in Calixarenes in the NanoWorld Eds. Vicens J, Harrowfield J, Springer, 2007
  • Calixarene-based anion receptors, Matthews SE and Beer PD Supramolecular Chemistry, 2006, 17 411-435.
  • Calixarene-based anion receptors, Matthews SE and Beer PD in Calixarenes 2001, Eds Asfari Z, Böhmer V, Harrowfield, J, Vicens J, Kluwer 2003

 

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or